The growing number of people living with Parkinson’s disease (PD), multiple sclerosis (MS) and motor neuron disease (MND) is being driven by different underlying factors, according to new research due to be presented at the European Academy of Neurology (EAN) Congress 2026 and published in Neurology.

UC San Francisco researchers have developed a new form of deep brain stimulation (DBS) that adjusts in real time as a person walks, helping improve gait and reduce falls in people with Parkinson’s disease. The study, publishing June 15 in Nature Medicine, demonstrates for the first time that an implanted brain stimulator can detect neural signals associated with each step and automatically adjust stimulation within fractions of a second. 

EPFL and CHUV researchers have developed the first AI-assisted, real-time deep-brain stimulation therapy for walking impairments in Parkinson’s disease.

Researchers at Aarhus University have developed ear-EEG, a technology that enables long-term monitoring of brain activity and sleep in people's homes. Already being used in clinical studies, the technology could help detect diseases such as Parkinson’s and Alzheimer’s years earlier than today. The article explores how emerging health technologies are shifting healthcare from hospitals to homes, and why the next challenge is building healthcare systems that can use them.

The number of patients living with neurodegenerative diseases that affect movement is rising steadily. Yet a large-scale study from the Paris Brain Institute and the Karolinska Institutet in Stockholm shows that this is not an emerging health crisis: the trend conceals very different realities, with direct implications for public health policy and research. The findings are published in Neurology.

Michael Koob, PhD, and his team from University of Minnesota Medical School have been selected to join the Collaborative Research Network (CRN)External link that opens in the same window, an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease, through a $6 million grant awarded by Aligning Science Across Parkinson’s (ASAP)External link that opens in the same window, in partnership with The Michael J. Fox Foundation for Parkinson’s Research (MJFF)External link that opens in the same window.